FDA Approves EPINEPHRINE — Amneal Pharmaceuticals of New York LLC

# FDA Approves Amneal Pharmaceuticals' Epinephrine Injection Amneal Pharmaceuticals of New York LLC has received FDA approval for its subcutaneous epinephrine injection (NDA020800), entering the established emergency treatment market where the company will compete against existing players in the critical auto-injector and injectable epinephrine segments. The approval strengthens Amneal's portfolio in emergency care products and positions the manufacturer to capture market share in the widely-used anaphylaxis treatment category.